PMC:7396557 / 50039-50163
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T394 | 57-65 | SP_7 | denotes | COVID-19 |
| T33173 | 57-65 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T294 | 57-65 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T434 | 6-9 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T375 | 0-124 | Sentence | denotes | SFJDC has been recommended in 15 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1373 | 57-65 | Disease | denotes | COVID-19 | MESH:C000657245 |